Top 10 global pharmaceutical companies by revenue 2023

The leading pharmaceutical company worldwide in 2023 was Johnson & Johnson, however, also including non-pharmaceutical sales. A global view on the industryThe total global pharmaceutical market was worth around 1.6 trillion U.S. dollars in 2023. North America remains the strongest regional market worldwide, responsible for nearly half of the global market size. The largest national pharmaceutical market is the United States, making up almost half of global medicine spending. Thus, five of the ten largest pharmaceutical companies worldwide were from the United States in 2023. One reason for this is that the U.S. is still the world’s largest hub for life sciences and medical research and knowledge. The importance of innovationPharmaceutical companies are to a considerable part – more than in most other industries – driven by the imperative to produce innovative products and to invest in research and development. Once a new drug, for example, is launched, the clock is already ticking towards the loss of patent protection. In particular, companies that depend on a small number of blockbuster drugs, are under threat of heavy revenue loss. Two effects of patent expirations for the pharma industry are high R&D concentration and a growing focus on specialty drugs.

在全球范围内，2023年引领行业的领先制药公司为强生公司（Johnson & Johnson），其销售范围亦包括非药品产品。从全球视角来看，2023年全球药品市场总值约为16万亿美元。北美地区依然保持着全球最强劲的区域市场地位，其市场规模几乎占据全球市场的半壁江山。美国作为最大的国家药品市场，占据了全球医药支出的近一半。因此，在2023年全球十大制药公司中，有五家来自美国。其背后原因之一是美国仍然是全球生命科学、医学研究及知识的最大中心。创新的重要性在制药行业中占据重要地位——相较于其他多数行业，制药公司更受到推出创新产品以及投资研发的迫切需求驱动。例如，一旦新药上市，其专利保护期限的时钟就已经开始倒计时。特别是那些依赖于少数重磅药物的制药公司，面临着巨额收入损失的风险。专利到期对制药行业产生的两大影响是研发投入的高度集中以及日益增长的专注于特殊药物的关注。